Related Experiment Video
Updated: Jan 25, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Genetic Burden in Congenital Anomalies of the Mitral and Tricuspid Valves: A Case-Control Study
Felix-Julian Campos-Garcia1,2,3,4, Addy-Manuela Castillo-Espinola5, Carolina-Elizabeth Medina-Escobedo2
1Doctoral Program in Medical Sciences, National Autonomous University of Mexico, Mexico City, Mexico.
Insights
Individuals with congenital heart defects, specifically atrioventricular valve anomalies and univentricular hearts, exhibit a higher genetic burden. This study found more common genetic variants in affected patients, highlighting a strong genetic predisposition for these complex heart conditions.
Area of Science:
- Cardiovascular Genetics
- Developmental Biology
- Human Genetics
Background:
- Congenital heart disease (CHD) is the most common birth defect, often multifactorial with genetic and environmental influences.
- Congenital anomalies of the atrioventricular valve or septum (CAAVAS) and functionally univentricular heart (FUH) are complex CHD subtypes linked to molecular pathway disruptions.
Purpose of the Study:
- To investigate the genetic burden contributing to CAAVAS and FUH.
- To identify specific genetic variants associated with these congenital heart anomalies.
Main Methods:
- Case-control study with 24 patients (CAAVAS/FUH) and 24 healthy controls.
- Whole-exome sequencing (WES) to evaluate genetic burden using gnomAD MAF and REVEL scores.
- Secondary filtration focused on 349 HPO-defined heart valve morphology genes.
Main Results:
- Significantly higher median number of common variants in the case group compared to controls (p=0.035).
- Identified variants in genes encoding contractile proteins (MYH3, ACTC1), ECM proteins (FBN1), ciliary proteins (EVC2), enzymes (POLG), signaling proteins (TGFB2), and transcription factors (NKX2-5).
Conclusions:
- Increased genetic burden and specific gene variants are significantly associated with CAAVAS and FUH.
- Findings reinforce a strong genetic predisposition for congenital mitral and tricuspid valve anomalies.
Abstract:
Congenital heart disease (CHD) is the most common congenital malformation, with most cases exhibiting a multifactorial etiology involving genetic and environmental factors. Congenital anomalies of the atrioventricular valve or septum (CAAVAS) and functionally univentricular heart (FUH) are complex subtypes of CHD, where disruptions in key molecular pathways are implicated. This study investigates the genetic burden contributing to these anomalies. This case-control study included 48 participants: 24 patients diagnosed with CAAVAS or FUH and 24 healthy controls. Whole-exome sequencing (WES) was conducted to assess genetic burden by evaluating minor allele frequencies (MAF) using gnomAD and predicting functional impact of variants with REVEL scores. A secondary filtration was performed, focusing on 349 genes associated with abnormal heart valve morphology (HP:0001654) as defined by the Human Phenotype Ontology (HPO) database, to identify pathogenic variants exclusive to the case group. Genetic burden risk (GBR) analysis revealed a significantly higher median number of common variants in the case group compared to controls (p = 0.035). Genetic analysis identified variants in genes involved in contractile cardiac and cytoskeletal proteins (MYH3, ACTC1), extracellular matrix proteins (FBN1, FREM1, HSPG2), ciliary proteins (EVC2, PKD1L1), enzymes (POLG, DNASE1L3), cell-signaling proteins (TGFB2, CCDC22) and transcription factors (NKX2-5, NONO). This study highlights the significant role of genetic burden and gene variants associated with congenital mitral and tricuspid valve anomalies. Our findings reinforce the strong genetic predisposition underlying these malformations, as evidenced by the increased genetic burden in affected individuals compared to controls without CHD.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
What is Population Genetics?

